241 related articles for article (PubMed ID: 11136566)
1. Identification of a basal/reserve cell immunophenotype in benign and neoplastic endometrium: a study with the p53 homologue p63.
O'Connell JT; Mutter GL; Cviko A; Nucci M; Quade BJ; Kozakewich HP; Neffen E; Sun D; Yang A; McKeon FD; Crum CP
Gynecol Oncol; 2001 Jan; 80(1):30-6. PubMed ID: 11136566
[TBL] [Abstract][Full Text] [Related]
2. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.
Glickman JN; Yang A; Shahsafaei A; McKeon F; Odze RD
Hum Pathol; 2001 Nov; 32(11):1157-65. PubMed ID: 11727253
[TBL] [Abstract][Full Text] [Related]
3. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
[TBL] [Abstract][Full Text] [Related]
4. Retinoid status controls the appearance of reserve cells and keratin expression in mouse cervical epithelium.
Darwiche N; Celli G; Sly L; Lancillotti F; De Luca LM
Cancer Res; 1993 May; 53(10 Suppl):2287-99. PubMed ID: 7683571
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of p63 in endometrial polyps: evidence that a basal cell immunophenotype is maintained.
Nogueira AA; Sant'Ana de Almeida EC; Poli Neto OB; Zambelli Ramalho LN; Rosa e Silva JC; Candido dos Reis FJ
Menopause; 2006; 13(5):826-30. PubMed ID: 16912659
[TBL] [Abstract][Full Text] [Related]
6. Expression of the p53 homologue p63 in early cervical neoplasia.
Quade BJ; Yang A; Wang Y; Sun D; Park J; Sheets EE; Cviko A; Federschneider JM; Peters R; McKeon FD; Crum CP
Gynecol Oncol; 2001 Jan; 80(1):24-9. PubMed ID: 11136565
[TBL] [Abstract][Full Text] [Related]
7. Histopathology of functional and neoplastic changes in cervix and endometrium.
Dallenbach-Hellweg G
Verh Dtsch Ges Pathol; 1997; 81():240-4. PubMed ID: 9474876
[TBL] [Abstract][Full Text] [Related]
8. Mucinous endometrial epithelial proliferations: a morphologic spectrum of changes with diverse clinical significance.
Nucci MR; Prasad CJ; Crum CP; Mutter GL
Mod Pathol; 1999 Dec; 12(12):1137-42. PubMed ID: 10619266
[TBL] [Abstract][Full Text] [Related]
9. p63 expression profile in normal and malignant prostate epithelial cells.
Davis LD; Zhang W; Merseburger A; Young D; Xu L; Rhim JS; Moul JW; Srivastava S; Sesterhenn IA
Anticancer Res; 2002; 22(6C):3819-25. PubMed ID: 12553000
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells.
Weinstein MH; Signoretti S; Loda M
Mod Pathol; 2002 Dec; 15(12):1302-8. PubMed ID: 12481011
[TBL] [Abstract][Full Text] [Related]
11. Distribution pattern and marker profile show two subpopulations of reserve cells in the endocervical canal.
Martens JE; Smedts FM; Ploeger D; Helmerhorst TJ; Ramaekers FC; Arends JW; Hopman AH
Int J Gynecol Pathol; 2009 Jul; 28(4):381-8. PubMed ID: 19483623
[TBL] [Abstract][Full Text] [Related]
12. Antibodies targeting p63 react specifically in the cytoplasm of breast epithelial cells exhibiting secretory differentiation.
Bratthauer GL; Saenger JS; Strauss BL
Histopathology; 2005 Dec; 47(6):611-6. PubMed ID: 16324199
[TBL] [Abstract][Full Text] [Related]
13. Adenomyoepithelial tumours and myoepithelial carcinomas of the breast--a spectrum of monophasic and biphasic tumours dominated by immature myoepithelial cells.
Hungermann D; Buerger H; Oehlschlegel C; Herbst H; Boecker W
BMC Cancer; 2005 Jul; 5():92. PubMed ID: 16050957
[TBL] [Abstract][Full Text] [Related]
14. [Expression of P53, P63, and C-erbB-2 in endometrioid adenocarcinoma and their clinicopathological significance].
Hu WF; Liu MQ; Zhao Q
Ai Zheng; 2004 Sep; 23(9):1021-5. PubMed ID: 15363194
[TBL] [Abstract][Full Text] [Related]
15. Roles of p63 in the diethylstilbestrol-induced cervicovaginal adenosis.
Kurita T; Mills AA; Cunha GR
Development; 2004 Apr; 131(7):1639-49. PubMed ID: 14998922
[TBL] [Abstract][Full Text] [Related]
16. Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas.
Kaufmann O; Fietze E; Mengs J; Dietel M
Am J Clin Pathol; 2001 Dec; 116(6):823-30. PubMed ID: 11764070
[TBL] [Abstract][Full Text] [Related]
17. Immunodetection of GLUT1, p63 and phospho-histone H1 in invasive head and neck squamous carcinoma: correlation of immunohistochemical staining patterns with keratinization.
Burstein DE; Nagi C; Kohtz DS; Lee L; Wang B
Histopathology; 2006 May; 48(6):717-22. PubMed ID: 16681688
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of p63 isoforms in normal tissues and neoplastic cells.
Nylander K; Vojtesek B; Nenutil R; Lindgren B; Roos G; Zhanxiang W; Sjöström B; Dahlqvist A; Coates PJ
J Pathol; 2002 Dec; 198(4):417-27. PubMed ID: 12434410
[TBL] [Abstract][Full Text] [Related]
19. p63 expression in solid cell nests of the thyroid: further evidence for a stem cell origin.
Reis-Filho JS; Preto A; Soares P; Ricardo S; Cameselle-Teijeiro J; Sobrinho-Simões M
Mod Pathol; 2003 Jan; 16(1):43-8. PubMed ID: 12527712
[TBL] [Abstract][Full Text] [Related]
20. p63 immunostaining in destained bronchoscopic cytological specimens.
Shtilbans V; Szporn AH; Wu M; Burstein DE
Diagn Cytopathol; 2005 Apr; 32(4):198-203. PubMed ID: 15754365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
